GNOMX Corp

Presymptom Health

This company develops AI-driven diagnostic tests and software that detect infection and sepsis in patients for use by healthcare providers and clinical labs.

Inflammatix

This company develops point-of-care molecular diagnostic tests for healthcare providers to identify acute infections and sepsis by reading the body's immune response.

Biocogniv

This company develops artificial intelligence software for hospital laboratories and emergency departments to predict time-critical conditions like sepsis from routine blood tests.

GLX Analytix

This company develops blood-based diagnostic and monitoring tests for clinicians to manage neurodegenerative, autoimmune and neuropsychiatric diseases using glycocalyx biomarkers and artificial intelligence.

Orbit Genomics

This company develops AI-powered genomic tests for healthcare providers and patients to diagnose lung cancer and evaluate risks for chronic diseases.

Qnomx

Qnomx develops an AI platform for molecular diagnostics laboratories to interpret genomic sequencing data and generate clinical reports for precision oncology.

Lucid Genomics

This company develops an artificial intelligence platform for long-read genomic data interpretation to assist clinical laboratories and pharmaceutical researchers with diagnostics.

Bayesian Health

This company develops an artificial intelligence platform for hospitals to detect early signs of patient deterioration and life-threatening conditions such as sepsis.